| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Joseph Klein III is Director at IONS. From July 2019 to July 2026, the filings on record show 0 open-market purchases and 22 sales. Joseph Klein III's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $445K at current prices.
Our model assigns Joseph Klein III a middling insider score of 62/100, based on 14 past trades. Over a 12-month horizon, 55.6% of those trades were profitable, with an average 12-month return of +1.7%.
The IONS filings lean toward selling, a net 176,205 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2019 | IONS Ionis Pharmaceuticals Inc | Director | Sell | 812 | $62.90 | $51,074.80 | -6.0% | |
| Nov 20, 2019 | IONS Ionis Pharmaceuticals Inc | Director | Sell | 2,000 | $60.00 | $120,000.00 | -12.9% |